摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(3-Tert-butylphenyl)-6-propylpyrimidine-2-carbonitrile | 1219941-44-2

中文名称
——
中文别名
——
英文名称
4-(3-Tert-butylphenyl)-6-propylpyrimidine-2-carbonitrile
英文别名
——
4-(3-Tert-butylphenyl)-6-propylpyrimidine-2-carbonitrile化学式
CAS
1219941-44-2
化学式
C18H21N3
mdl
——
分子量
279.385
InChiKey
UFQYUTMOGQOOFL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.8
  • 重原子数:
    21
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.39
  • 拓扑面积:
    49.6
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    4-propyl-6-trimethylstannanyl-pyrimidine-2-carbonitrile 、 1-溴-3-叔丁基苯 在 bis-triphenylphosphine-palladium(II) chloride 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 生成 4-(3-Tert-butylphenyl)-6-propylpyrimidine-2-carbonitrile
    参考文献:
    名称:
    2-Phenyl-9H-purine-6-carbonitrile derivatives as selective cathepsin S inhibitors
    摘要:
    Starting from previously disclosed equally potent cathepsin K and S inhibitor 4-propyl-6-(3-trifluoromethylphenyl) pyrimidine-2-carbonitrile 1, a novel 2-phenyl-9H-purine-6-carbonitrile scaffold was identified to provide potent and selective cathepsin S inhibitors. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.06.049
点击查看最新优质反应信息

文献信息

  • Design and optimization of a series of novel 2-cyano-pyrimidines as cathepsin K inhibitors
    作者:Zoran Rankovic、Jiaqiang Cai、Jennifer Kerr、Xavier Fradera、John Robinson、Ashvin Mistry、Emma Hamilton、George McGarry、Fiona Andrews、Wilson Caulfield、Iain Cumming、Maureen Dempster、John Waller、Paul Scullion、Iain Martin、Ann Mitchell、Clive Long、Mark Baugh、Paul Westwood、Emma Kinghorn、John Bruin、William Hamilton、Joost Uitdehaag、Mario van Zeeland、Dominique Potin、Laurent Saniere、Andre Fouquet、François Chevallier、Hortense Deronzier、Cecile Dorleans、Eric Nicolai
    DOI:10.1016/j.bmcl.2010.01.100
    日期:2010.3
    Morphing structural features of HTS-derived chemotypes led to the discovery of novel 2-cyano-pyrimidine inhibitors of cathepsin K with good pharmacokinetic profiles, for example, compound 20 showed high catK potency (IC(50) = 4 nM), >580-fold selectivity over catL and catB, and oral bioavailability in the rat of 52%. (C) 2010 Elsevier Ltd. All rights reserved.
  • 2-Phenyl-9H-purine-6-carbonitrile derivatives as selective cathepsin S inhibitors
    作者:Jiaqiang Cai、D. Jonathan Bennett、Zoran Rankovic、Maureen Dempster、Xavier Fradera、Jonathan Gillespie、Iain Cumming、William Finlay、Mark Baugh、Sylviane Boucharens、John Bruin、Kenneth S. Cameron、William Hamilton、Jennifer Kerr、Emma Kinghorn、George McGarry、John Robinson、Paul Scullion、Joost C.M. Uitdehaag、Mario van Zeeland、Dominique Potin、Laurent Saniere、Andre Fouquet、Francois Chevallier、Hortense Deronzier、Cecile Dorleans、Eric Nicolai
    DOI:10.1016/j.bmcl.2010.06.049
    日期:2010.8
    Starting from previously disclosed equally potent cathepsin K and S inhibitor 4-propyl-6-(3-trifluoromethylphenyl) pyrimidine-2-carbonitrile 1, a novel 2-phenyl-9H-purine-6-carbonitrile scaffold was identified to provide potent and selective cathepsin S inhibitors. (C) 2010 Elsevier Ltd. All rights reserved.
查看更多